Global Acute Bacterial Skin & Skin Structure Infections Treatment Market (ABSSI) By Infection Type (Hospital-Acquired ABSSI and Community-Acquired ABSSI), By Drug Type (Oral and Parental Antibiotics), By Route of Administration (Oral, Parental, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032
- Published date: June 2024
- Report ID: 95316
- Number of Pages: 348
- Format:
-
keyboard_arrow_up
-
-
- Paratek Pharmaceuticals, Inc.
- Merck & Co., Inc.
- Melinta Therapeutics, Inc.
- AbbVie Inc. Company Profile
- Sandoz International GmbH
- Glenmark Pharmaceuticals
- Teva Pharmaceutical Industries Ltd. Company Profile
- Sun Pharmaceutical Industries Limited
- Aceragen, Inc.
- Pfizer Inc Company Profile
- Allergen
- Cumberland Pharmaceutical Industries Ltd.
- Aurobindo Pharma Ltd.
- Accord Healthcare ltd. (a subsidiary of Intas Pharmaceuticals Ltd.)
- Cadila Healthcare Ltd.
- Other Key Players
- settingsSettings
Our Clients
- 95316
- June 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
